Kelly Leboeuf Fahnoe

Kelly LeBoeuf Fahnoe possesses extensive experience in protein science and research management, currently serving as Senior Director at Q32 Bio Inc. since September 2017, where previous roles included Director and Associate Director in the same field. Concurrently, Kelly is a Senior Scientist for a startup linked to Atlas Ventures. Prior experience includes a tenure at Celgene from November 2011 to September 2017 as a Scientist II, following a role at Avila Tx as Principal Research Associate until its acquisition by Celgene. Kelly began a career at Pfizer Global Research & Development, working as a Scientist from 2001 to November 2011. Academic credentials include a Bachelor of Science in Chemistry from Michigan State University, earned between 1997 and 2001.